Oxford Begins First Human Trials for Bundibugyo Ebola Vaccine
The University of Oxford has officially launched the first human trial for a vaccine specifically targeting the Bundibugyo strain of Ebola, marking a critical step in global efforts to combat the deadly virus. This trial represents a significant advancement in developing defenses against this particular strain.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)Sources
First human trial of Bundibugyo Ebola vaccine begins
The early-stage trial will enroll 50 healthy adults to assess the vaccine's safety and immune response.
Read full article →Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to combat an outbreak spreading in the Democratic Republic of Congo and Uganda.
By Abubakar Ibrahim
Read full article →Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN
Oxford launches first human trials for Bundibugyo Ebola vaccine MSN
Read full article →Coverage Timeline
Related Stories

Fijian Rugby Player Dies in Japan From Suspected Severe Heatstroke
27m ago

Motorcycle-Car Collision in Chalkidiki Leaves One Injured
42m ago

82-Year-Old Injured After Car Catches Fire While Refueling in Mittelsachsen
46m ago

Nigerian Government Provides Anti-Snake Venom to Benue State Amid Rising Deaths
48m ago